Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is a 40 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $1.488 million which beat the analyst consensus estimate of $888.833 thousand by 67.41 percent. This is a 8.38 percent increase over sales of $1.373 million the same period last year.